Flagship Pioneering as of March 31, 2019
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 8 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 45.3 | $1.2B | 59M | 20.35 | |
| Rubius Therapeutics | 26.2 | $693M | 38M | 18.10 | |
| Kaleido Biosciences Ord (KLDO) | 9.5 | $252M | 17M | 14.50 | |
| Denali Therapeutics (DNLI) | 7.0 | $186M | 8.0M | 23.22 | |
| Evelo Biosciences | 5.5 | $146M | 18M | 8.00 | |
| Seres Therapeutics (MCRB) | 3.3 | $87M | 13M | 6.87 | |
| Quanterix Ord (QTRX) | 2.0 | $52M | 2.0M | 25.83 | |
| Syros Pharmaceuticals | 1.1 | $29M | 3.2M | 9.14 |
